Atlas Trials

Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Clinical trial NCT07660211 · RECRUITING

Trial details

NCT number
NCT07660211
Sponsor
VitsGen Therapeutics Inc.
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
PSMA-positive Metastatic Castration-resistant Prostate Cancer (mCRPC)
Start date
2026-06-16
Primary completion
2027-05-06
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.